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Lack of a system for site-specific genetic manipulation has severely hindered studies on the molecular
biology of all Bartonella species. We report the first site-specific mutagenesis and complementation for a
Bartonella species. A highly transformable strain of B. bacilliformis, termed JB584, was isolated and found to
exhibit a significant increase in transformation efficiency with the broad-host-range plasmid pBBR1MCS-2,
relative to wild-type strains. Restriction analyses of genomic preparations with the methylation-sensitive
restriction enzymes ClaI and StuI suggest that strain JB584 possesses a dcm methylase mutation that con-
tributes to its enhanced transformability. A suicide plasmid, pUB1, which contains a polylinker, a pMB1
replicon, and a nptI kanamycin resistance cassette, was constructed. An internal 508-bp fragment of the B.
bacilliformis flagellin gene (fla) was cloned into pUB1 to generate pUB508, a fla-targeting suicide vector.
Introduction of pUB508 into JB584 by electroporation generated eight Kanr clones of B. bacilliformis. Char-
acterization of one of these strains, termed JB585, indicated that allelic exchange between pUB508 and fla had
occurred. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immunoblotting, and electron
microscopy showed that synthesis of flagellin encoded by fla and secretion/assembly of flagella were abolished.
Complementation of fla in trans was accomplished with a pBBR1MCS recombinant containing the entire
wild-type fla gene (pBBRFLAG). These data conclusively show that inactivation of fla results in a bald,
nonmotile phenotype and that pMB1 and REP replicons make suitable B. bacilliformis suicide and shuttle
vectors, respectively. When used in conjunction with the highly transformable strain JB584, this system for
site-specific genetic manipulation and complementation provides a new venue for studying the molecular
biology of B. bacilliformis.
The Bartonella genus comprises a unique group of intracel-
lular bacteria that employ arthropod-mediated transmission
and hemotrophy as common parasitic strategies. Recent taxo-
nomic reclassifications have expanded the number of Bar-
tonella species from one, B. bacilliformis, to 11 based on se-
quence homology and genetic relatedness. Five of these
species are presently considered agents of emerging infectious
disease in humans (B. bacilliformis, B. clarridgeiae, B. elizabe-
thae, B. henselae, and B. quintana), and the diseases share the
symptoms of bacteremia, hemolytic anemia, recurrent fever,
and a variety of vascular lesions (for recent reviews, see refer-
ences 5, 25, and 34).
B. bacilliformis is the etiologic agent of a biphasic disease
that is indigenous to the Andes mountain region of South
America. Oroya fever is commonly used to describe the first
phase, which is characterized by an acute syndrome of fever,
malaise, and severe hemolytic anemia (16, 37, 46). Humans
exhibit the acute hematic phase of disease within 2 to 3 weeks
following inoculation of Bartonella into the bloodstream by the
bite of a nocturnal sandfly, Lutzomyia verrucarum (20). Subse-
quent erythrocyte invasion accompanies a severe hemolytic
anemia that is responsible for the high (40 to 80%) mortality
rate observed in the absence of antibiotic therapy (20, 24, 28).
The disease has killed over 10,000 humans in recorded time
(20, 46). The chronic secondary phase of the disease, termed
verruga peruana, develops approximately 4 weeks after the
primary phase and is characterized by angiomatous cutaneous
eruptions (20). During this phase, the bacteria invade vascular
endothelial cells (14, 15, 32) and subsequently stimulate the
formation of new blood vessels (14), a common sequela of
bartonelloses. Recent reports of several atypical monophasic
(verruga peruana) cases of B. bacilliformis in previously dis-
ease-free lowland elevations are cause for concern (2, 4).
Although a conjugative system for random Tn5-based mu-
tagenesis has been reported for B. henselae (12), no means of
site-directed mutagenesis exists for Bartonella species. This
lack has been a major impediment to elucidating the molecular
biology of this expanding group of emerging bacterial patho-
gens and was the impetus for the present study. Here we
describe a system for site-specific mutagenesis and comple-
mentation of B. bacilliformis. This is the first report of site-
specific mutagenesis and complementation for any of the Bar-
tonella species.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Escherichia coli strains used for
propagation of plasmids were grown overnight at 37°C in Luria-Bertani medium
with antibiotic supplements when required (11). The strains of B. bacilliformis
and E. coli used or generated in this study are summarized in Table 1. B.
bacilliformis was routinely grown on heart infusion agar (Difco, Detroit, Mich.)
supplemented with 5% defibrinated sheep erythrocytes and 2.5% filter-sterile
sheep serum (Quad Five, Ryegate, Mont.) at 30°C in a water-saturated atmo-
sphere. Antibiotic supplements for B. bacilliformis included kanamycin sulfate
(25 mg/ml), and chloramphenicol (1 mg/ml) (both from Sigma Chemical Co., St.
Louis, Mo.) and were used individually or combined depending upon the exper-
imental conditions. Plates were routinely cultured by transferring growth from
the surface of a 5-day culture plate to a fresh plate, using an initial plating density
of approximately 4,000 CFU/plate. Since no suitable liquid growth medium is
currently available for B. bacilliformis, the growth phase of the bacterium at
harvest could not be determined. However, to ensure that the bartonellae were
actively growing, colonies were first observed at 3 days and subsequently har-
vested at 5 days postinoculation.
For testing the motility of B. bacilliformis strains, a Bartonella motility medium
was devised. The defibrinated sheep erythrocyte supplement of standard Bar-
tonella growth medium was replaced with sheep erythrocyte lysate (8) at a 5%
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final concentration to yield a translucent medium suitable for visual scoring, and
the agar in the medium was reduced to 0.2% (wt/vol). Plates were poured and
dried for 48 h at 22°C and dried for an additional 1 h at 45°C prior to inoculation,
to reduce moisture on the surface of the agar.
Preparation and manipulation of DNA. Chromosomal DNA from B. bacilli-
formis was prepared with CTAB (cetyltrimethylammonium bromide) by the
methods of Ausubel et al. (6). Plasmid DNA for cloning was isolated from E. coli
by the alkali lysis procedure of Birnboim and Doly (9). Plasmid DNA for elec-
troporation experimentation was prepared with a Midi-Prep kit (Qiagen, Chats-
worth, Calif.) or a Perfect Prep kit (5 PRIME-3 PRIME, Boulder, Colo.) as
specified by the manufacturer. Cloning was accomplished by purifying individual
DNA fragments from ethidium bromide-stained agarose gels with either a Gene-
Clean kit (Bio 101, Inc., La Jolla, Calif.) or a QIAquick kit (Qiagen). Ligation
and transformation of DNA into E. coli DH5a was done by standard procedures
(38). The plasmids used in this study are summarized in Table 1.
DNA hybridization analysis. Genomic DNA from B. bacilliformis strains and
plasmid DNA were isolated, digested to completion with appropriate restriction
enzymes, and resolved on ethidium bromide-stained 1% (wt/vol) agarose gels.
The gels were blotted onto a supported nitrocellulose membrane (pore size,
0.45-mm; Schleicher & Schuell, Keene, N.H.) by the method of Southern (41)
and baked for 1 h at 80°C. DNA probes were made by random primer extension
with [a-32P]dCTP (New England Nuclear, Boston, Mass.) and were used to
probe blots overnight at 50°C as previously described (7). The blots were then
washed at high stringency and exposed for 1 h to X-ray film (X-Omat XAR-5;
Eastman Kodak Co., Rochester, N.Y.) as previously described (7) to visualize
hybridized DNA fragments.
Electroporation. Approximately seven plates of 5-day-cultured B. bacilliformis
cells were harvested into 1 ml of heart infusion broth at 4°C. The cells were
subsequently washed four times with 1 ml of ice-cold 10% (vol/vol) glycerol in
water with intermittent centrifugations at 2,090 3 g for 20 min at 4°C. The final
bacterial concentration was measured with a Petroff-Hauser counter and ad-
justed to 1010 cells/ml with 10% glycerol. Electrotransformation was performed
with a gene pulser with 0.2-cm cuvettes (Bio-Rad Laboratories, Hercules, Calif.)
that had been chilled on ice for at least 15 min. In general, a 44-ml bacterial
suspension (1010 cells/ml) was combined with 1 to 2 ml of DNA (1 to 44 mg/ml)
and electroporated with an exponential-decay waveform set at a field strength of
12.5 kV/cm, a pulse time of 5 ms, and capacitance held constant at 25 mF as
previously described for Bartonella (19, 36). Immediately following electropora-
tion, cells were removed from the cuvette by being resuspended in 1 ml of
ice-cold sterile recovery broth (heart infusion broth containing 0.5% [wt/vol]
bovine serum albumin, 5% [vol/vol] sheep erythrocyte lysate [8] and 5 mM
L-methionine). The suspension was then transferred to a 15-ml sterile tube and
incubated for 14 h at 30°C in a water-saturated atmosphere. This incubation
period corresponds to approximately two B. bacilliformis generation times (8)
and was used to allow antibiotic resistance marker expression. Transformants
were isolated by being plated on standard Bartonella growth medium supple-
mented with kanamycin and/or chloramphenicol, when required for selection.
Antibiotic-resistant colonies usually appeared after 6 to 7 days of incubation at
30°C.
PCR and oligonucleotides. PCR amplification was achieved with a GeneAmp
2400 thermocycler (Perkin-Elmer, Norwalk, Conn.) by procedures developed by
Mullis and Faloona (35). Reaction mixtures contained 10 mM Tris-HCl (pH 8.3),
50 mM KCl, 200 mM each deoxynucleoside triphosphate, 4 mM MgCl2, 2.5 U of
AmpliTaq DNA polymerase (Perkin-Elmer), 1 to 100 ng of template DNA, and
0.1 mg of each primer. The reaction proceeded for 30 cycles of 1 min at 94°C, 1
min at 50 to 60°C (depending on the calculated primer melting temperature),
and 1 min at 72°C with an initial 5-min denaturation at 94°C and a final 7-min
extension at 72°C. Single-stranded oligonucleotide primers specific for the fla
gene, FLA59 (59-AAGCTTTAGAGATTGTTTTGCAAA-39) and FLA39 (59-A
AATATTCTGGCTGCCCTGATTTGC-39), and the kanamycin cassette, NPTI59
(59-AGCCACGTTGTGTCTCAAAATCTC-39) and NPTI39 (59-CGTCCCGTC
AAGTCAGCGTAATGC-39), were synthesized by The University of Montana
Murdock Molecular Biology Facility. The “junction” amplimer set was designed
to detect the integration of the pUB508 suicide plasmid at the fla locus and
consisted of primers NPTI59 and FLA39. The target loci for each of the primers
are illustrated in Fig. 1.
SDS-PAGE and immunoblotting. Whole-cell extracts of B. bacilliformis were
prepared by boiling in sodium dodecyl sulfate (SDS) sample buffer for 10 min
and were separated by SDS-polyacrylamide gel electrophoresis (PAGE) (12.5%
[wt/vol] acrylamide), using procedures adapted from those of Laemmli (30).
Approximately 20 mg of total extract protein was added per lane. Protein bands
were visualized by staining with Coomassie brilliant blue (38). For immunoblots,
separated proteins were electrophoretically transferred from gels to supported
nitrocellulose membranes (pore size, 0.45 mm; Schleicher & Schuell) by the
methods of Towbin et al. (43). Immunoblots were developed by using the rabbit
anti-flagellin antiserum and procedures described by Scherer et al. (39).
Transmission electron microscopy (TEM). B. bacilliformis was grown and
harvested into 1 ml of heart infusion broth at 4°C. The cells were washed three
times with 10% (vol/vol) glycerol at 4°C, with intermittent centrifugations at
2,090 3 g for 20 min at 4°C, and finally resuspended in 10% glycerol. Aliquots of
this suspension (15 ml) were placed on Formvar-coated 300-mesh copper-palla-
dium grids (Electron Microscopy Sciences, Fort Washington, Pa.) and incubated
for 5 min at 22°C. The grids were then stained with 2% uranyl acetate (pH 7.0)
for 3 min, destained with 1 M ammonium acetate (pH 7.0) for 3 min, and washed
with deionized water for 1 min. They were then air dried and observed at 75 kV
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics Source orReference
Strains
B. bacilliformis
KC583 Neotype strain 10
KC584 Peruvian isolate, 1963 10
HG584 Highly passaged KC584 transformed with pEST (Kmr, dcm mutant) 19
JB584 HG584 cured of pEST (Kms) This study
JB585 fla gene of JB584 interrupted by insertion of pUB508 (Kmr, fla) This study
JB686 JB585 complemented in trans by transformation with pBBRFLAG (Kmr Cmr, fla1) This study
E. coli
DH5a Host strain used for cloning and propagation of plasmids 17
Plasmids
pUC18,19 Cloning vectors; RepEc, Ap
r 47
pBK-CMV Genomic library cosmid; RepEc, Km
r 42
pBBR1MCS B. bacilliformis shuttle vector; RepEc, RepBb, Cm
r 27
pBBR1MCS-2 B. bacilliformis shuttle vector; RepEc, RepBb, Km
r 26
pUCK18 pUC18 containing Kmr cassette (nptI); RepEc, Ap
r, Kmr 36
pUCK19 pUC19 containing ;1,500-bp PstI fragment of pUCK18; RepEc, Ap
r, Kmr This study
pUB1 Suicide plasmid; pUCK19 with a 1,118-bp BglII fragment removed to delete bla; RepEc, Km
r This study
pUB508 Flagellin-targeting suicide plasmid; pUB1 containing internal 508-bp Kpn-BglII fragment of fla;
RepEc, Km
r
This study
pAUL1 pBK-CMV containing 3,800-bp B. bacilliformis Sau3AI fragment with intact fla gene; RepEc, Km
r This study
pFLAG3 pUC18 containing 1,400-bp HindIII-EcoRI fragment of pAUL1 with intact fla gene; RepEc, Ap
r This study
pBBRFLAG Complementation shuttle vector; pBBR1MCS containing 2,158-bp HindIII fragment of pAUL1
with fla gene; RepEc, RepBb, Cm
r
This study
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FIG. 1. Illustration of suicide plasmid and schematic representation of site-specific fla disruption. (A) The B. bacilliformis suicide plasmid pUB1 harbors a multiple
cloning site, the kanamycin resistance cassette neomycin phosphotransferase I (nptI), and the pMB1 replicon. (B) The flagellin gene-targeting suicide plasmid, derived
from pUB1, is shown with the 508-bp BglII-KpnI internal fragment of fla (fla9) The transformable strain, JB584 (Kms, fla1), containing the wild-type 1,127-bp fla ORF,
is shown. Homologous recombination resulted in site-specific insertion of pUB508 at the fla locus, generating strain JB585 (Kmr, fla). Note the position of the flagellin
(FLA59 and FLA39) and kanamycin (NPTI59 and NPTI39) amplimers, indicated by the small arrows. (Figure not drawn to scale.)
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with a 7100 transmission electron microscope (Hitachi, Mountain View, Calif.)
located at The University of Montana Electron Microscopy Center.
Cloning the B. bacilliformis flagellin gene (fla). The B. bacilliformis flagellin
gene, fla, was chosen as the locus to develop a system of site-specific mutagenesis
for two reasons. First, fla exists as a mapped, single-copy gene in B. bacilliformis
(29), and mutations in fla are rarely lethal. Second, the phenotype associated
with the gene is readily observable by TEM and easily scored by testing for
motility.
fla was cloned, sequenced, and submitted to GenBank by another group (3).
The fla gene was simultaneously isolated by our laboratory from a lZAP Express
(Stratagene Cloning Systems, La Jolla, Calif.) expression library of B. bacillifor-
mis by using rabbit anti-flagellin antiserum. A pBK-CMV cosmid clone contain-
ing the entire fla gene in a 3,800-bp Sau3AI fragment was subsequently excised
from the l clone as specified by the manufacturer (Stratagene) and termed
pAUL1.
Purified pAUL1 was digested with HindIII, and the 2,158-bp fragment con-
taining fla was isolated by agarose gel electrophoresis (1% [wt/vol] agarose) and
purified by using a GeneClean II kit (Bio 101). Ligation of this fragment into the
HindIII site of pUC18 resulted in pFLAG3, a source of fla DNA fragments for
constructing the fla-targeting suicide plasmid.
Construction of suicide and shuttle/complementation plasmids. The suicide
plasmid pUB1 (Fig. 1A) was constructed in several steps. Previous studies
showed that the pMB1 replicon was not recognized by the replicational machin-
ery of Bartonella species (19, 36). Therefore, we reasoned that this replicon could
be used to construct a suicide vector for Bartonella. To construct the plasmid, a
;1,500-bp PstI fragment containing the nptI gene, encoding neomycin-kanamy-
cin resistance, was subcloned from pUCK18 into pUC19, resulting in pUCK19.
Subsequently, the b-lactamase (bla) gene of pUCK19 was deleted by removing a
1,118-bp BglII fragment and religated to generate pUB1 (Fig. 1A). To create a
flagellin-specific suicide plasmid for insertional mutagenesis experiments, a
508-bp KpnI-BglII fragment from pFLAG3 containing an internal portion of fla
was cloned into pUB1 to produce pUB508 (Fig. 1B).
A complementation shuttle plasmid, pBBRFLAG, was constructed by cloning
the 2,158-bp HindIII fragment of pAUL1 into the broad-host-range vector
pBBR1MCS. The resulting plasmid, pBBRFLAG, contains a chloramphenicol
resistance cassette, the entire wild-type fla gene, and a REP replicon which is
recognized by the replicational machinery of B. bacilliformis (see below).
RESULTS
Isolation of a highly transformable strain. Grasseschi and
Minnick previously reported mean transformation efficiencies
of 7.8 3 105 following electroporation-mediated introduction
of the cosmid pEST into B. bacilliformis KC584 (19). pEST is
a cosmid harboring an RK2 origin of replication and a neo-
mycin phosphotransferase I (nptI) gene encoding kanamycin
resistance (36). We attempted to repeat these experiments
with B. bacilliformis KC584 but were unable to isolate stable
transformants. Electroporation-mediated introduction of a va-
riety of constructs designed to disrupt genes in wild-type B.
bacilliformis KC583 and KC584 were also unsuccessful. These
trials included introduction of a variety of linear (double-
stranded and single-stranded) and circular gene-targeting con-
structs designed to mutagenize two separate loci, fla and gyrB
(7). A number of methods designed to either alleviate restric-
tion (13, 21–23, 40, 44) or promote homologous recombination
(1, 18, 31) were used in conjunction with the various gene-
targeting constructs without success (data not shown).
The discrepancy between the reported transformation effi-
ciencies and those found at the onset of this study suggested
that one or more spontaneous mutations probably altered the
genetic background of the KC584 strain used by Grasseschi
and Minnick (19), resulting in a highly transformable strain of
B. bacilliformis. To test this hypothesis, we obtained a frozen
stock of the Kanr pEST-containing strain of B. bacilliformis
(herein termed HG584) and cured this strain of the pEST
cosmid by three passages, for a total of 15 days, in the absence
of kanamycin sulfate. Six randomly selected clones were then
subcultured independently and tested for sensitivity to kana-
mycin sulfate (25 mg/ml). All six clones exhibited wild-type
sensitivities to kanamycin, and two of these Kans clones were
cultivated and their genomic DNA was isolated. DNA hybrid-
ization analyses with a 32P-radiolabeled pEST probe did not
detect pEST in the genome (data not shown), suggesting that
the cosmid was cured from these two strains. Further verifica-
tion by using PCR and nptI amplimers (NPTI59 and NPTI39)
confirmed the absence of the Kanr marker (see Fig. 2, lane 2).
One of these cured, Kans clones was termed JB584.
The transformation efficiency of JB584 was subsequent-
ly assessed by electroporation-mediated introduction of
pBBR1MCS-2. This plasmid was chosen because it is more
stably maintained than the cosmid pEST and the multiple
cloning site of pBBR1MCS plasmids enabled efficient cloning
for complementation analyses. JB584 demonstrated a transfor-
mation efficiency of 5.2 3 103 transformants per mg of
pBBR1MCS-2, which corresponds to one transformant per
8.4 3 104 cells. This value is within the lower range of efficiency
reported by Grasseschi and Minnick (19); however, the rela-
tively higher DNA concentrations (1 mg) and the different
replicon used in the present study may account for the lower
relative efficiency. Electroporation lethality, previously esti-
mated at 31% (19), was not considered here or in the previous
study when calculating the transformation efficiency of B. ba-
cilliformis. Here, our focus was not on optimizing
pBBR1MCS-2 electrotransformation but simply on isolating a
strain that would efficiently serve as a host for allelic exchange
experiments. Taken as a whole, these results demonstrated
that the genetic background of the KC584 host strain used by
Grasseschi and Minnick (19) was distinct from wild-type
KC584 and suggested that JB584 would be an efficient host for
allelic exchange experiments.
We hypothesized that the increased transformability of
JB584 was due to one or more spontaneous mutations in the
restriction-modification system, whereby restriction of intro-
duced foreign DNA was reduced to a level that permitted
plasmid replication and maintenance. To test this hypothesis,
we compared genomic digests of KC583, KC584, JB584,
HG584, JB585, and JB686 by using the methyl-sensitive re-
striction enzymes StuI (dcm sensitive) and ClaI (dam sensi-
tive), with BamHI (methyl insensitive) as a positive control.
Subsequent agarose gel electrophoresis revealed that StuI was
able to digest genomic DNA from strains HG584, JB584,
JB585, and JB686 but was unable to digest DNA from KC583
or KC584. These data strongly suggest that a dcm methylase is
active in wild-type strains KC583 and KC584 and that the sites
of methylation overlap the StuI recognition sequence. In con-
trast, ClaI and BamHI digestion of genomic DNA was evident
in of all of the strains mentioned and there was no apparent
difference in activity among any of the strains. There was no
significant difference in the growth rate, colony morphology, or
overt phenotypes between strains KC584 and JB584, suggest-
ing that JB584 was suitable for use as a host strain for mu-
tagenesis experiments. These results, combined with the pre-
viously mentioned descrepancies between the transformation
efficiencies, strongly suggest that loss of dcm methylase activity
occurred during the multiple passages of the KC584 strain
used in the Grasseschi and Minnick (19) study and also suggest
that JB584 and HG584 have essentially the same restriction-
modification system genetic alterations and the curing event
itself did not alter this genetic background. Because this highly
passaged KC584 strain was no longer viable, we were resigned
to curing the previously transformed strain (HG584) and using
the resulting strain (JB584) for our subsequent manipulation
studies.
Characterization of Kanr mutants by PCR. Eight kanamy-
cin-resistant clones were isolated following electroporation-
mediated introduction of pUB508 into JB584. Three amplimer
sets, designated nptI, fla, and junction, were used to character-
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ize the genotype of the eight Kanr clones (refer to Fig. 1B for
a schematic representation of amplimer target loci).
First, the nptI amplimer set (NPTI59 and NPTI39) generated
a product in all eight Kanr strains, consistent with the expected
983-bp size (data not shown). This verified that the Kanr phe-
notype exhibited by these strains was not a result of natural
mutation. The transformation efficiency was approximately 3.3
transformants per mg of pUB508, corresponding to one stable
integrant per 1.6 3 109 cells. Figure 2 shows the product
generated by the nptI amplimer set from one of these Kanr
transformants, termed strain JB585 (Fig. 2, lane 3), and its
absence from the parent strain, JB584 (lane 2).
Second, the fla amplimer set (FLA59 and FLA39) generated
the expected 1,304-bp flagellin PCR product with the parent
strain JB584 (Fig. 2, lane 4) and, in contrast, was absent from
the Kanr strain JB585 (lane 5). This showed that the homolo-
gous recombination event occurred at the fla locus in JB585.
Of the eight Kanr strains, two were analyzed with the fla am-
plimer set, and neither generated a product. We were unable
to generate the expected ;4.2-kb product resulting from am-
plification of the entire mutagenized locus spanning the in-
serted pUB508, even when the elongation time was increased
to 2.5 min.
Finally, the junction amplimer set (NPTI59 and FLA39) was
used to verify the hypothesized chromosomal fusion between
the inserted nptI and the mutagenized fla. The ;2,300-bp
product generated from JB585 (Fig. 2, lane 9), as well as its
absence from the parent strain (lane 6), confirms that the
insertion of pUB508 occurred at fla as illustrated in Fig. 1B. In
addition, as controls, pUB508 (lane 7) and a mixture of
pUB508 and JB584 DNA (lane 8) were amplified with the
junction amplimer set to further substantiate these results,
since neither reaction produced an amplicon.
Characterization of the complemented mutant by PCR. To
develop a Bartonella system for in trans complementation, we
restored the wild-type flagellin phenotype to a fla mutant.
Plasmid pBBRFLAG, containing fla, a chloramphenicol resis-
tance cassette, and a REP origin, was introduced into JB585 by
electroporation. Transformants were selected on medium con-
taining kanamycin sulfate (25 mg/ml) and chloramphenicol (1
mg/ml) and resulted in the isolation of strain JB686. Initial
confirmation of in trans complementation was accomplished by
electrophoretic analysis of PCR products. The fla amplimer set
(FLA59 and FLA39) was used to detect the presence of the
plasmid-located fla gene, which was absent in the fla mutant
strain JB585 (Fig. 2, lane 5) but was present in both JB584 and
the complemented mutant JB686 (lanes 4 and 10, respective-
ly). Finally, the ;2,300-bp product generated by the junction
amplimer set (NPTI59 and FLA39) demonstrated that the
chromosomal fla mutation was still present in the comple-
mented mutant strain, JB686 (lane 11).
Characterization by DNA hybridization. To further substan-
tiate the genotype of the mutant and trans-complemented
strains, high-stringency DNA hybridizations were performed
(Fig. 3). Southern blots probed with the 32P-labeled wild-type
fla PCR product (generated with the FLA59 and FLA39 am-
plimers) produced a distinct two-band hybridization pattern in
ClaI-digested genomic DNA in strains containing the dis-
rupted fla gene, i.e., JB585 (Fig. 3B, lane 4) and JB686 (lane 5).
In addition, the pBBRFLAG complementation plasmid is
clearly visible as a separate genetic element (Fig. 3A, lane 5).
Analysis of flagellin production in generated strains by
SDS-PAGE and immunoblotting. SDS-PAGE and immuno-
blotting were used to determine the effect of the pUB508
insertion on the synthesis of flagellin in the mutant strain,
JB585, and the complemented strain, JB686 (Fig. 4). The wild-
type 1,127-bp B. bacilliformis fla open reading frame (ORF)
encodes a 42-kDa polypeptide (39). When whole-cell lysates
were visualized by SDS-PAGE, the flagellin polypeptide was
clearly synthesized in strain JB584 (Fig. 4A, lane 1). In con-
trast, the fla mutant, JB585 (lane 2), lacked the 42-kDa flagel-
FIG. 2. Electrophoretic analysis of PCR products derived from B. bacillifor-
mis fla mutant and trans-complemented strains. PCR products generated by
amplification of chromosomal DNA obtained from parent and recombinant
strains by using three amplimer sets, nptI (NPTI59 and NPTI39), fla (FLA59 and
FLA39), and junction (jct) (NPTI59 and FLA39) were respectively used to detect
the kanamycin cassette, the flagellin gene, and the junction between fla and the
inserted pUB508. Bars below the gel indicate the amplimer set used in each
reaction. Amplimer sets and the respective DNA templates used in this analysis
are as follows: lane 1 (NPTI59 and NPTI39, Fla59 and Fla39; no template), lane
2 (NPTI59 and NPTI39; JB584), lane 3 (NPTI59 and NPTI39; JB585), lane 4
(FLA59 and FLA39; JB584), lane 5 (FLA59 and FLA39; JB585), lane 6 (NPTI59
and FLA39; JB584), lane 7 (NPTI59 and FLA39; pUB508), lane 8 (NPTI59 and
FLA39; pUB508 1 JB584), lane 9 (NPTI59 and FLA39; JB585), lane 10 (FLA59
and FLA39 JB686), lane 11 (NPTI59 and FLA39 JB686). PCR products were
resolved by agarose gel electrophoresis (1% agarose) and visualized by ethidium
bromide staining. DNA size markers (lane M) are shown to the right.
FIG. 3. Detection of the flagellin gene in wild-type, mutant, and trans-com-
plemented strains of B. bacilliformis by DNA hybridization. (A) Ethidium bro-
mide-stained agarose gel (1% [wt/vol] agarose) containing l HindIII size stan-
dards (lane 1), ClaI-digested chromosomal DNA from KC584 (lane 2), JB584
(lane 3), JB585 (lane 4), and JB686 (lane 5), and ClaI-digested pBBRFLAG
(lane 6). (B) Corresponding Southern blot following hybridization with the fla
probe. Note the distinct two-band hybridization pattern in strains containing a
disrupted fla gene (strains JB585 and JB686) and the presence of pBBRFLAG
in the trans-complemented strain, JB686.
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lin polypeptide, suggesting that flagellin synthesis had been
disrupted. Finally, the 42-kDa flagellin polypeptide was clearly
evident in the trans-complemented strain (lane 3), indicating
that fla expression and synthesis was occurring from the plas-
mid locus. Immunoblot analysis was subsequently performed
by reacting whole-cell lysates with rabbit anti-flagellin poly-
clonal antiserum. The immunoblot confirmed the presence of
the flagellin polypeptide in strains JB584 and JB686 (Fig. 4B,
lanes 1 and 3, respectively) and also demonstrated that flagel-
lin synthesis was completely abolished in the mutant strain
JB585 (lane 2). A truncated flagellin product was not observed
in the mutant strain analyzed by this procedure.
Ultrastructural characterization of strains by TEM. TEM
was used to visualize the secretion and assembly of flagella in
each of the strains (Fig. 5). Electron micrographs showed that
the wild-type strain, KC584 (Fig. 5A), and the transformable
strain, JB584 (Fig. 5B), maintained the normal synthesis, se-
cretion, and assembly of flagellin polypeptides, resulting in the
wild-type lophotrichous flagella. Second, as evidenced by the
lack of flagellar filaments, the flagellin ORF of strain JB585
had been insertionally disrupted and the synthesis, secretion,
and assembly of the flagellin polypeptide into filaments was
abolished (Fig. 5C). Finally, not only did the complemented
mutant, strain JB686, synthesize flagellin polypeptides from
the plasmid locus, but also these polypeptides were secreted
and assembled (Fig. 5D) as in the wild-type strain (Fig. 5A).
Therefore, the flagellar phenotypes of the strains were consis-
tent with the genotypes. There was no significant difference in
the number of flagellar filaments or wavelength of the flagellar
filaments, including in flagellated strains of JB584 containing
pBBRFLAG or pBBR1MCS (data not shown).
Motility phenotypes of generated strains. Initially, phase-
contrast microscopy was used to examine wet mounts of each
strain. By using this method, a loss of motility was observed for
strain JB585, whereas strains KC584, JB584, and JB686 exhib-
ited indistinguishable motility phenotypes. Motility was subse-
quently assessed by the ability of the bacterium to spread
within Bartonella motility medium. To develop the assay, we
tested a wild-type strain in motility medium with agar concen-
trations ranging from 0.2 to 0.8% by stabbing the medium with
an inoculation needle from 5-day-old cultures. Incubation for 7
days at 30°C demonstrated that agarose concentrations above
0.6% inhibited motility. However, at agarose concentrations of
0.4 and 0.2%, motility produced a uniform halo of growth
within the medium away from the site of inoculation. The
strains generated in this study were subsequently tested in the
same way by using Bartonella motility medium containing 0.2%
agar. Multiple inoculations with each of the strains consistently
generated indistinguishable and uniform halos of growth for
strains KC584, JB584, and JB686, indicating that neither the
modified genotype resulting in enhanced transformability
(JB584) nor fla expression from an extrachromosomal locus
(JB686) has a detectable effect on motility. In contrast, the
mutant strain, JB585, was nonmotile and did not produce a
halo (data not shown).
In conclusion, site-directed insertion of pUB508 at the fla
locus of JB584 generated the fla mutant, JB585, which lacks
flagellin expression and is nonmotile. Subsequent electropora-
tion-mediated introduction of pBBRFLAG into strain JB585
generated the trans-complemented strain, JB686, which has a
motility phenotype that is indistinguishable from KC584.
FIG. 4. Analysis of flagellin synthesis in the B. bacilliformis fla mutant and
complemented mutant by SDS-PAGE and immunoblotting. (A) Whole-cell ex-
tracts of parent, flagellin mutant, and trans-complemented mutant strains were
separated by SDS-PAGE (12.5% polyacrylamide) and stained with Coomassie
brilliant blue. The 42-kDa flagellin polypeptide is present in the parent strain
JB584 (lane 1) and is absent from the kanamycin-resistant flagellin mutant strain
JB585 (lane 2). Flagellin synthesis is detected in trans from the complementation
plasmid pBBRFLAG in strain JB686 (lane 3). (B) Corresponding immunoblot
reacted with rabbit anti-flagellin polyclonal antiserum, indicating that flagellin
synthesis is restored in the trans-complemented strain. Molecular mass standards
are indicated to the left (in kilodaltons), and the 42-kDa flagellin polypeptide is
marked by the arrow.
FIG. 5. Ultrastructure of generated strains as shown by TEM. Transmission
electron micrographs were prepared by staining 5-day-old cultures of B. bacilli-
formis with 2% uranyl acetate. Flagella are observed the wild-type strain (KC584)
(A) and the transformable strain (JB584) (B) but are absent from the fla mutant
strain (JB585) (C) Polypeptide synthesis, secretion, and assembly of the flagella
is restored in the trans-complemented strain (JB686) (D). Bars, 0.5 mm.
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DISCUSSION
The ability to genetically manipulate an organism is essential
for a better understanding of its molecular biology. In vivo
genetic manipulation of a bacterium generally consists of two
fundamental techniques, transformation and mutagenesis.
These techniques utilize constructs consisting of circular plas-
mids or linear fragments of DNA that possess genetic elements
specific to the manipulation desired. These DNA constructs
can be introduced into the bacterium by natural (conjugation
and transduction) or artificial (electroporation and chemical)
methods. In this study, we used electroporation to introduce a
variety of plasmids (both replicative and nonreplicative) and
linear DNA fragments and were able to demonstrate plasmid
transformation, site-directed mutagenesis, and complementa-
tion in trans within B. bacilliformis.
Plasmid transformation was first demonstrated in Bartonella
by electrotransformation of the cosmid pEST into B. (previ-
ously Rochalimaea) quintana (36) and was subsequently ac-
complished in B. bacilliformis by Grasseschi and Minnick using
the same cosmid (19). In both studies, the Bartonella species
recognized the RK2 origin of replication but did not recognize
pMB1, ColE1, or F origins. These observations, combined with
our results, suggested that pUB1 (harboring the pMB1 origin)
could be used as a suicide plasmid for all Bartonella species. In
the course of our research, we determined that the most con-
sistent replicon for high transformation efficiencies in B. bacil-
liformis was the broad-host-range vector pBBR1MCS (27) and
its derivatives (26), which contain the REP origin of replica-
tion.
Random mutagenesis by using chemical methods, UV light,
or transposons is designed to generate nonspecific mutations
that are subsequently selected by phenotypic or biochemical
means. The major drawbacks to random mutagenesis are the
difficulty in mutant isolation and the generation of secondary
nonspecific mutations. These anomalous secondary mutations
are of special concern when assessing the pathogenesis of an
organism, since the virulence potential of a specific gene and
gene product are in question relative to a wild-type back-
ground. Dehio and Meyer recently reported successful conju-
gation between E. coli and B. henselae as a means of plasmid
transfer and delivery of Tn5 transposons on suicide plasmids
for random gene inactivation (12).
Site-specific mutagenesis, the focus of this study, consists of
two general methods, replacement recombination and inser-
tional recombination, wherein single mutations are introduced
at a specific genomic locus. Replacement recombination in-
volves linear fragments of DNA designed so that during ho-
mologous recombination two crossover events result in the
replacement of a target locus with the construct. We attempted
replacement recombination with both single- and double-
stranded linear DNA targeting two loci, gyrB (7) and fla, with-
out success. Even when the highly transformable strain, JB584,
was used as the host, replacement recombination was not
achieved. However, insertional recombination with a circular
segment of DNA, where a single homologous recombination
event inserts the entire element into the chromosome, was
successful in demonstrating site-specific genetic manipulation,
as described in Results.
After several initial attempts to mutagenize the flagellin
gene failed, we realized that there were in vivo barriers imped-
ing homologous recombination in B. bacilliformis. This
prompted us to try alternative methods for alleviating restric-
tion-modification systems as well as biochemical and metabolic
manipulations previously shown to increase the likelihood of
homologous recombination. Although numerous manipula-
tions were attempted, the generation of strain JB584 was the
critical step toward successful mutagenesis. It is likely that a
spontaneous mutation occured in a multiply-passaged KC584
strain used by Grasseschi and Minnick (19), allowing them to
obtain exaggerated “wild-type” transformation efficiencies. By
curing this Kanr HG584 strain of pEST, which resulted in
JB584, we obtained a strain with a significant increase in trans-
formation efficiencies, which encouraged us to use this strain as
the parent for successful mutagenesis experiments.
In addition to being sequence specific, restriction enzymes
such as StuI and ClaI are methylation sensitive, where restric-
tion occurs only in the absence of methylation, enabling the
organism to recognize self and nonself. While the genotype of
JB584 is not fully known, genomic DNA extracted from this
strain differed from that of the wild-type strain in that it was
StuI sensitive, indicating a different methylation pattern and
suggesting that a dcm methylase gene had been mutated. Since
the altered methylation pattern did not result in lethal self-
restriction of JB584, we speculate that a second mutation in
the cognate restriction enzyme had occurred and that a lack of
restriction enzyme activity explained the enhanced transform-
ability of this strain. Alternatively, and more probably, a single,
spontaneous mutation event involving the deletion of closely
linked restriction and modification genes would also explain
the phenotype of JB584. It is likely that wild-type strains of B.
bacilliformis retain both an active dcm methylase and the cog-
nate restriction enzyme and that they digest foreign DNA, but
strains such as JB584 have lost the cognate restriction enzyme
to ensure survival and do not digest foreign DNA. However, a
full characterization of the specific restriction endonuclease
mutation(s) in strain JB584 enabling higher transformation
efficiencies remains to be determined.
The hybridization data generated in this study suggest that
the B. bacilliformis flagellar filament is encoded by a single
flagellin gene, whereas many bacteria possess multisubunit fla-
gella. Furthermore, the data produced in this study conclu-
sively show that inactivation of a single fla gene completely
abolishes synthesis of the flagellum and generates a nonmotile
and nonflagellated (bald) strain. The lophotrichous flagella of
B. bacilliformis and the high degree of motility that they impart
have been implicated as virulence determinants in several re-
ports (8, 33, 39, 45). The strains generated in this study provide
the molecular means to assess Koch’s postulates and thus more
fully define the role of flagella in the pathogenesis of B. bacil-
liformis. Using the highly transformable strain, JB584, the
pBBR1MCS shuttle vectors, and the fla-specific suicide plas-
mid, we have demonstrated site-specific mutagenesis and
complementation for the first time in any Bartonella species.
Two additional loci (ialB and the 16S–23S rDNA intergenic
spacer) have subsequently been manipulated in our laboratory
by using this system.
The Bartonella species are notoriously difficult to manipulate
genetically. We have developed a system for electroporation-
mediated site-specific mutagenesis and complementation for
B. bacilliformis. The pBBR1MCS series of broad-host-range
vectors were shown to be useful shuttle vectors for B. bacilli-
formis, and recent work in our laboratory with B. quintana
shows that the REP origin is functional in other Bartonella
species. We have constructed a suicide vector (pUB1) with a
polylinker, which is ideally suited for manipulating any desired
target gene in B. bacilliformis. As stated above, a spontaneous
or natural mutation was apparently present in the host strain
used by Grasseschi and Minnick (HG584) (19) and resulted in
the inflated transformation efficiencies that they reported. The
data produced in this study suggest that a strain of Bartonella
with enhanced transformability can be isolated by selecting
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clones that are capable of maintaining a replicative plasmid,
such as pBBR1MCS-2. Subsequent curing of these potential
methylase restriction mutants can result in a well-defined,
transformable host strain for subsequent mutagenesis experi-
ments.
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